Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A6

    
• • ·Information for Readers

    Page :A7

    

• Curriculum in Cardiology

  • ·Appropriate Cardiac Cath Lab activation: Optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction

    Page :995

    Ivan C. Rokos, William J. French, Amal Mattu, Graham Nichol, Michael E. Farkouh, James Reiffel, Gregg W. Stone

    Résumé Résumé Plan Plan  
  • ·Prediction of severe cardiovascular events by VE/Vco₂ slope versus peak Vo₂ in systolic heart failure: A meta-analysis of the published literature

    Page :1004-1014

    Rosana Poggio, Hernán Cohen Arazi, Mariano Giorgi, Santiago G. Miriuka

    Résumé Résumé Plan Plan  
  • ·Angiographic assessment of microvascular perfusion—Myocardial blush in clinical practice

    Page :1015-1022

    Italo Porto, Christian Hamilton-Craig, Marta Brancati, Francesco Burzotta, Leonarda Galiuto, Filippo Crea

    Résumé Résumé Plan Plan  

• Cardiac Safety Research Consortium

  • ·The Cardiac Safety Research Consortium electrocardiogram warehouse: Thorough QT database specifications and principles of use for algorithm development and testing

    Page :1023-1028

    Paul Kligfield, Cynthia L. Green, Justin Mortara, Philip Sager, Norman Stockbridge, Michael Li, Joanne Zhang, Samuel George, Ignacio Rodriguez, Daniel Bloomfield, Mitchell W. Krucoff

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux

    Page :1029

    Philippe Gabriel Steg, Shamir Mehta, Sanjit Jolly, Denis Xavier, Hans-Juergen Rupprecht, Jose Luis Lopez-Sendon, Susan Chrolavicius, Sunil V. Rao, Christopher B. Granger, Janice Pogue, Shiona Laing, Salim Yusuf

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

    Page :1035

    Laura Mauri, Dean J. Kereiakes, Sharon-Lise T. Normand, Stephen D. Wiviott, David J. Cohen, David R. Holmes, Sripal Bangalore, Donald E. Cutlip, Michael Pencina, Joseph M. Massaro

    Résumé Résumé Plan Plan  
  • ·Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale

    Page :1042-1048

    Ole Fröbert, Bo Lagerqvist, Thórarinn Gudnason, Leif Thuesen, Roger Svensson, Göran K. Olivecrona, Stefan K. James

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial

    Page :1049-1055

    Tjeerd E. van Rees Vellinga, Ron J.G. Peters, Salim Yusuf, Rizwan Afzal, Susan Chrolavicius, Martin O'Donnell, Shamir R. Mehta, Wadys?aw Pluta, Jerzy Sacha, John W. Eikelboom

    Résumé Résumé Plan Plan  
  • ·Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: A pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY

    Page :1056

    Mark Y. Chan, Jie L. Sun, Tracy Y. Wang, Renato D. Lopes, Marc E. Jolicoeur, Karen S. Pieper, Sunil V. Rao, L. Kristin Newby, Kenneth W. Mahaffey, Robert A. Harrington, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality

    Page :1065-1071

    Amit P. Amin, John A. Spertus, Kimberly J. Reid, Xiao Lan, Donna M. Buchanan, Carole Decker, Frederick A. Masoudi

    Résumé Résumé Plan Plan  
  • ·Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative

    Page :1072-1078

    Daniel W. Mudrick, Anita Y. Chen, Matthew T. Roe, L. Kristin Newby, W. Brian Gibler, E. Magnus Ohman, Eric D. Peterson, Karen P. Alexander

    Résumé Résumé Plan Plan
  • ·The golden hour of prehospital reperfusion with triple antiplatelet therapy: A sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy

    Page :1079-1084

    Ton Heestermans, Arnoud W.J. van 't Hof, Jurriën M. ten Berg, Jochem W. van Werkum, Eric Boersma, Arend Mosterd, Pieter R. Stella, Arthur B. van Zoelen, A.T. Marcel Gosselink, Waclav Kochman, Thorsten Dill, Petra C. Koopmans, Gert van Houwelingen, Felix Zijlstra, Christian Hamm

    Résumé Résumé Plan Plan  
  • ·ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance

    Page :1085-1091

    Jacob Lønborg, Lene Holmvang, Henning Kelbæk, Niels Vejlstrup, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Peter Clemmensen, Marek Treiman, Jan S. Jensen, Thomas Engstrøm

    Résumé Résumé Plan Plan  
  • ·Anthropometric measures after Fontan procedure: Implications for suboptimal functional outcome

    Page :1092

    Meryl S. Cohen, Victor Zak, Andrew M. Atz, Beth F. Printz, Nelangi Pinto, Linda Lambert, Victoria Pemberton, Jennifer S. Li, Renee Margossian, Carolyn Dunbar-Masterson, Brian W. McCrindle

    Résumé Résumé Plan Plan  
  • ·Linking clinical registry data with administrative data using indirect identifiers: Implementation and validation in the congenital heart surgery population

    Page :1099-1104

    Sara K. Pasquali, Jeffrey P. Jacobs, Gregory J. Shook, Sean M. O'Brien, Matthew Hall, Marshall L. Jacobs, Karl F. Welke, J. William Gaynor, Eric D. Peterson, Samir S. Shah, Jennifer S. Li

    Résumé Résumé Plan Plan  
  • ·Growth differentiation factor 15—an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts

    Page :1105-1112

    Tanja M. Raedle-Hurst, Karsten Koenigstein, Frank Gruenhage, Jochen Raedle, Eva Herrmann, Hashim Abdul-Khaliq

    Résumé Résumé Plan Plan  
  • ·Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis

    Page :1113-1120

    See Hooi Ewe, Nina Ajmone Marsan, Mauro Pepi, Victoria Delgado, Gloria Tamborini, Manuela Muratori, Arnold C.T. Ng, Frank van der Kley, Arend de Weger, Martin J. Schalij, Melissa Fusari, Paolo Biglioli, Jeroen J. Bax

    Résumé Résumé Plan Plan  
  • ·Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: Results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry

    Page :1121

    Chiara Melloni, Bimal R. Shah, Fang-Shu Ou, Matthew T. Roe, Sidney C. Smith, Charles V. Pollack, Magnus Ohman, W. Brian Gibler, Eric D. Peterson, Karen P. Alexander

    Résumé Résumé Plan Plan  
  • ·Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG)

    Page :1130

    Usman Javed, Prakash C. Deedwania, Deepak L. Bhatt, Christopher P. Cannon, David Dai, Adrian F. Hernandez, Eric D. Peterson, Gregg C. Fonarow

    Résumé Résumé Plan Plan  
  • ·Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1

    Page :1137

    Deepak Bhakta, Miriam R. Groh, Changyu Shen, Robert M. Pascuzzi, William J. Groh

    Résumé Résumé Plan Plan  
  • ·Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure

    Page :1142-1148

    Kirkwood F. Adams, Mandeep R. Mehra, Ron M. Oren, Christopher M. O'Connor, Jun R. Chiong, Jalal K. Ghali, Daniel J. Lenihan, Stephanie H. Dunlap, J. Herbert Patterson, Todd A. Schwartz, G. Michael Felker

    Résumé Résumé Plan Plan  
  • ·Serum albumin and mortality in acutely decompensated heart failure

    Page :1149-1155

    Shanmugam Uthamalingam, Jagdesh Kandala, Marilyn Daley, Eshan Patvardhan, Robert Capodilupo, Stephanie A. Moore, James L. Januzzi

    Résumé Résumé Plan Plan  
  • ·Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure

    Page :1156-1162

    Sanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, Kazutomo Goto, Daisuke Goto, Takashi Yokota, Satoshi Yamada, Hisashi Yokoshiki, Akira Takeshita, Hiroyuki Tsutsui

    Résumé Résumé Plan Plan  
  • ·The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women

    Page :1163-1169

    Tariq Ahmad, Daniel I. Chasman, Samia Mora, Guillaume Paré, Nancy R. Cook, Julie E. Buring, Paul M. Ridker, I-Min Lee

    Résumé Résumé Plan Plan
  • ·Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention

    Page :1170-1177

    Giancarlo Marenzi, Monica De Metrio, Mara Rubino, Gianfranco Lauri, Annalisa Cavallero, Emilio Assanelli, Marco Grazi, Marco Moltrasio, Ivana Marana, Jeness Campodonico, Andrea Discacciati, Fabrizio Veglia, Antonio L. Bartorelli

    Résumé Résumé Plan Plan  
  • ·Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study

    Page :1178-1184

    Jack C.J. Sun, Kevin H.T. Teoh, Andre Lamy, Tej Sheth, Mary Lou Ellins, Hyejung Jung, Salim Yusuf, Sonia Anand, Stuart Connolly, Richard P. Whitlock, John W. Eikelboom

    Résumé Résumé Plan Plan
  • ·Health status and behavior among middle-school children in a midwest community: What are the underpinnings of childhood obesity?

    Page :1185-1189

    Taylor F. Eagle, Roopa Gurm, Caren S. Goldberg, Jean DuRussel-Weston, Eva Kline-Rogers, LaVaughn Palma-Davis, Susan Aaronson, Catherine M. Fitzgerald, Lindsey R. Mitchell, Bruce Rogers, Patricia Bruenger, Elizabeth A. Jackson, Kim A. Eagle

    Résumé Résumé Plan Plan
  • ·Correction

    Page :1190

    

• Letters to the Editor

  • ·Hypoalbuminemia as a risk factor of incident heart failure in the elderly

    Page :e39

    Stephane Arques

    
  • ·Gopal response to Arques

    Page :e41

    Deepa Mangalat Gopal, Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, Javed Butler

    
  • ·Identification of paroxysmal atrial fibrillation also for primary prevention of embolic stroke

    Page :e43

    Oscar M.P. Jolobe

    
  • ·Response from the authors to: Identification of paroxysmal atrial fibrillation also for primary prevention of embolic stroke

    Page :e45

    Anil-Martin Sinha, Johannes Brachmann, Hans-Christoph Diener, Carlos A. Morillo, Tommaso Sanna, Richard A. Bernstein, Vincenzo Di Lazzaro, Rod Passman, Marilyn Rymer, Frank Beckers

    
  • ·Elevation of high-sensitivity cardiac troponin T and composite end points in randomized trials

    Page :e47

    Iñigo Lozano, Vicente Barriales, Juan Rondan, Concepcion Suarez

    
  • ·Elevation of high-sensitivity cardiac troponin T and composite end points in randomized trials: Author reply

    Page :e49

    Toshiaki Otsuka, Tomoyuki Kawada, Chikao Ibuki, Yoshihiko Seino